GENEVA, Sept. 18 -- BIODLINK BIOPHARM CO., LTD. filed a patent application (CN2026/081556) for “METHOD FOR PREPARING PROTEIN-DRUG CONJUGATE BY MEANS OF DUAL-SITE SITE-SPECIFIC CONJUGATION”. With publication no. WO/2026/184670, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12P 21/02

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....